Health · Healthcare & Policy · 16 hrs ago
Latin American health leaders urge Korea to share technology, not just aid
Health leaders in Brazil and Latin America want partnerships that build local capacity, rather than aid that simply supplies finished medicines and equipment.
The COVID-19 pandemic exposed how vulnerable countries can be when medicine supply chains fail, and many now want to produce more health products themselves.
Brazil aims to raise domestic production of key health products to 70% by 2033 and requires technology transfer and joint production for some companies seeking access to its public health market.
Regional health groups also want Korean companies to work with local partners on diagnostic tests, including tests for diseases that are hard to diagnose in low-resource settings.
In Rio de Janeiro’s Rocinha neighborhood, a shorter tuberculosis treatment program helped raise treatment completion from below 50% to more than 95%.
The leaders say Korea’s diagnostic and biotech expertise could support local health systems, while giving Korean firms a role in shared production and research.
With Korea set to lead the G20 in 2028, they want it to make global health cooperation, chronic disease care and continued health funding priorities.
Latin American health leaders urged South Korea to share technology and build production partnerships rather than provide aid alone.
They said countries want to produce vaccines and medicines themselves after supply-chain failures during the COVID-19 pandemic.
Brazil aims to raise domestic production of key health products to 70% by 2033.
Officials called for Korean expertise in diagnostics, biotechnology and primary health care to support regional health capacity.
They also urged South Korea to make global health a priority when it chairs the G20 in 2028.
- Who
- Health leaders and international health representatives from Latin America urged South Korea to become a technology partner.
- What
- They called for technology transfer, local production partnerships and greater cooperation in diagnostics and health care.
- When
- The article was published on November 20, 2026. The G20 meeting chaired by South Korea is scheduled for 2028.
- Where
- The calls focused on Latin America, including Brazil and Paraguay.
- Why
- The leaders said countries want greater health self-reliance after pandemic-era supply-chain failures and want better access to diagnostics and treatments.
This story does not have two clearly opposing sides.
Brazil chaired the G20 and led the launch of the Global Alliance for Local and Regional Production, Innovation and Equitable Access.
The article says the reporter visited Fiocruz in Brazil.
Yonhap published the article urging South Korea to pursue health technology partnerships.
South Korea is due to chair the G20.
- Brazil health-products target
- 70% domestic production by 2033
- Brazil public health institution
- Oswaldo Cruz Foundation (Fiocruz)
- Treatment completion in Rocinha
- More than 95%, up from below 50%
- Short-course TB protocol
- Once weekly for three months
- South Korea’s G20 chair year
- 2028
What people are saying
Multinational pharmaceutical companies must transfer technology to local institutions and engage in joint production to enter Brazil’s large public procurement market (SUS).
If you develop a treatment but have no diagnostic equipment to accurately identify patients in the field, it is useless.
For medical innovation to reach patients, innovation in point-of-care testing devices is urgently needed, and the excellent technology of Korean companies can fill this gap.
South Korea, with its rich experience in chronic disease management and strengthening primary health care, should bring this issue to the forefront at the 2028 G20.